Global Reach & Clinical Development Infrastructure

Evestia Clinical helps biotechnology and pharmaceutical companies advance multinational clinical development through integrated global expertise, regional operational leadership and collaborative scientific partnership.

Our Approach

Global Clinical Development Built Around Biotech Innovation

Global clinical development is about more than opening sites in multiple countries. Multinational programs require consistent program governance, integrated Clinical Operations, coordinated Regulatory Affairs, experienced regional teams and one accountable partner.

Evestia Clinical combines central program leadership with local operational expertise. Our Full-Service CRO and FSP Solutions models provide flexible, agile program delivery, working as an integrated scientific partner throughout global clinical development.

One Accountable Partner

Central program governance across every participating country, with a single point of accountability for operational quality and timelines.

Local Expertise, Global Oversight

Regional regulatory knowledge and established investigator relationships, coordinated through central program leadership.

Senior Engagement Throughout

Senior leaders who remain directly engaged throughout international program delivery. Faster decisions, greater program continuity at every milestone.

Flexible Delivery Models

Full-Service CRO and FSP Solutions that scale with program complexity and program evolution, without permanent infrastructure investment.

Global Partnership

Built for Global Clinical Development

Successful multinational development depends on more than geographical reach. It requires one accountable partner, integrated scientific leadership, regional operational expertise and consistent program governance coordinated across every participating country.

Evestia Clinical provides centralized program leadership alongside regional regulatory and operational knowledge, maintaining coordinated regulatory strategy and multinational program continuity from study initiation through global submission. Sponsors work with one team, one governance model and one committed partner throughout every stage of international development.

Track Record

Global Reach at a Glance

With 12 offices across 10 countries spanning Europe, North America and Asia-Pacific, Evestia Clinical combines global program leadership with local expertise to support successful multinational studies.

12+

Offices Worldwide

Across 10 countries

Europe, NA & APAC

Regional Coverage

Three major clinical markets

Phase I–IV & Post Marketing

Clinical Development Support

End-to-end global delivery

Global

Regulatory & Operational Expertise

FDA, EMA, MHRA and beyond

Global Coverage

Global Clinical Development Network

Hover over each region to explore our clinical development capabilities, regulatory expertise and operational presence across global markets.

Global Clinical Network
24/7 Global Support

12

Offices

3

Regions

24/7

Global Support

United Kingdom & North America
Europe
Asia-Pacific (Australia)
Global Strategy

Why Global Reach Matters

Successful clinical development is built upon access to international patient populations, specialist investigator sites and region-specific regulatory expertise.

Evestia Clinical combines global program oversight with local operational knowledge to help sponsors coordinate multinational clinical programs. Our Clinical Operations and Regulatory Affairs teams coordinate across jurisdictions, from study planning through final submission.

  • Support efficient international patient recruitment through established site networks
  • Access specialist treatment centers across multiple countries
  • Coordinate regional regulatory requirements across FDA, EMA and MHRA
  • Maintain consistent study quality across global investigator sites
  • Support multinational Phase I–IV & Post-Marketing programs from a single accountable partner
Global Quality

Global Quality Standards

All Evestia Clinical programs are delivered under harmonised quality systems aligned with ICH-GCP, regional regulatory requirements and sponsor-specific governance expectations.

Our integrated quality framework helps ensure consistency, compliance and coordinated operational delivery across multinational clinical development programs, from Phase I first-in-human studies through global Phase III registration studies.

ICH-GCP Aligned

All programs delivered under harmonised quality systems meeting international GCP standards.

Multi-Jurisdictional

Regulatory expertise across FDA, EMA, MHRA and additional global health authorities.

Centralized Oversight

Integrated governance ensuring consistent quality and operational standards across all sites.

Experienced Teams

Senior clinical professionals with direct experience across multinational program delivery.

Regional Expertise

Regional Clinical Development Expertise

Operational teams with regional knowledge, regulatory familiarity and established investigator networks across Europe, North America and Asia-Pacific.

EMA, MHRA, national competent authorities

Europe

Supporting studies across major European clinical research markets from offices in Letchworth Garden City, Berlin, Lyon, Madrid, Milan, Warsaw, Steinhausen and Hoofddorp.

Regional Capabilities

Clinical OperationsRegulatory AffairsSite ManagementMonitoringData Management

Countries

United Kingdom, Germany, France, Spain, Italy, Poland, Switzerland, Netherlands

Office Locations

Letchworth Garden City (UK)Berlin (Germany)Lyon (France)Madrid (Spain)Milan (Italy)Warsaw (Poland)Steinhausen (Switzerland)Hoofddorp (Netherlands)
FDA, Health Canada

North America

Supporting clinical development programs through US-based operational expertise across offices in Charlottesville, Boston and South San Francisco, combined with global program leadership and sponsor engagement.

Regional Capabilities

Clinical OperationsRegulatory AffairsSite ManagementMonitoringBiostatistics

Countries

United States

Office Locations

Charlottesville, VABoston, MASouth San Francisco, CA
TGA, regional health authorities

Asia-Pacific

Providing regional support for international clinical development programs and global study execution across Asia-Pacific markets from our office in Iluka, Western Australia.

Regional Capabilities

Clinical OperationsStudy ManagementRegulatory CoordinationSite Support

Countries

Australia

Office Locations

Iluka, WA
Global Regulatory Strategy

Global Regulatory Expertise

International clinical trials require coordinated regulatory submissions, ethics approvals and country-specific requirements across multiple jurisdictions simultaneously.

Integrated Regulatory Affairs expertise streamlines submissions and supports coordinated program delivery. Our regulatory teams have experience across:

FDA (United States)
EMA (European Union)
MHRA (United Kingdom)
Ethics Committees
National Competent Authorities
Country-Specific Approvals

Integrated regulatory strategy from Study Start-Up through submission supports coordinated program delivery across multinational clinical development programs.

Access to Specialist Patient Populations

Access to Specialist Patient Populations

Many programs require access to geographically dispersed patient populations and specialist treatment centers, particularly where populations are small or concentrated at specialist sites.

Our global infrastructure provides access to specialist investigators, treatment centers and patient populations, supporting patient-centerd recruitment strategies and sustained program enrollment.

Operational Reach

Global Program Delivery Beyond Office Locations

While Evestia Clinical maintains offices across key clinical research markets, our operational reach is strengthened through established investigator networks, strategic partnerships and coordinated study management.

Our Clinical Trial Management teams coordinate multinational program delivery through centralized governance and oversight that spans geographies and regulatory environments. As a Global CRO, we support sponsors preparing for international studies or extending existing programs into new markets.

Why Evestia Clinical

Why Sponsors Choose Evestia Clinical for Global Development

One Accountable Global Partner

Central program leadership with coordinated regional delivery across every participating country.

Regional Expertise

Experienced teams with local regulatory and operational knowledge across Europe, North America and Asia-Pacific.

Flexible Delivery Models

Full-Service CRO and Functional Service Provider support tailored to sponsor needs and program evolution.

Built for Biotechnology

Supporting growing biotechnology organizations through flexible resourcing, scientific collaboration and senior program leadership.

Partner With Us

Ready to Discuss Your Global Development Program?

Whether expanding into international markets or managing a multinational registration program, Evestia Clinical provides integrated delivery, regional expertise and global infrastructure to advance your development program.

Our teams combine regional knowledge with centralized oversight across Phase I through Phase IV & Post-Marketing, spanning Oncology, Rare Disease and other specialist therapeutic areas.